The Healthier Life
Receive valuable daily health tips and advice FREE by email
The Daily Health
Nutrition and Healing
Search our database of articles.

ABCDEFGHIJKLMNOPQRSTUVWXYZ
Keyword Search
 

Related products

migraine

MIGRAINES & HEADACHES: Highly Recommended

Special Report on a new class 2 medical device that relieves headaches and migraines in 93% of patients trialled.
more info...
Dr Jonathan Wright

Dr Jonathan Wright

America's 'miracle' medic is now writing exclusively for our readers in the UK. Claim his 6-volume 'Library of Natural Healing' FREE!
more info...
PRELOX

PRELOX - SAVE UP TO 25%

Discover the sizzling sex secret of men who stay firm after forty
more info...
Super Foods Book

NEW! . . . SUPER FOODS FOR A SUPER-HEALTHY YOU

Unleash the secret healing power of Nature's ultimate foods - & 'programme' your body to remain free of illness
more info...

More Controversy Surrounding The Diabetes Drug Avandia


Date: 05/06/07
 
Keywords: Heart Disease,
The mainstream has finally caught up with HSI again. In 2003 we first told you about a link between the diabetes drug Avandia and an increased risk of congestive heart failure. Now, three and a half years later, the New England Journal of Medicine (NEJM) has made headlines with a study that illustrates just how expansive this danger really is. But here's what the recent headlines haven't mentioned: Increased risk of heart attack is just part of Avandia's risk profile.

Surgeon's KnifeIf you’d rather avoid an appointment with this man, then sign-up to the FREE Daily Health eletter...
where good health comes naturally!

The mainstream has finally caught up with HSI again. 
 
In 2003 we first told you about a link between the diabetes drug Avandia and an increased risk of congestive heart failure. Now, three and a half years later, the New England Journal of Medicine (NEJM) has made headlines with a study that illustrates just how expansive this danger really is. 
 
But here's what the recent headlines haven't mentioned: Increased risk of heart attack is just part of Avandia's risk profile.  
 
Slow going  
 
You might wonder how the US Food and Drug Administration (FDA) responded to the NEJM study. On the very day the study was published online, FDA officials issued a safety alert. That's an impressive lightning-fast response to controversy. Meanwhile, response to safety is not quite as swift: According to an agency spokesman, the FDA has been evaluating Avandia heart risks for nearly 10 months. 
 
And here's the frosting on the cake. Dr. Robert J. Meyer of the FDA's Center for Drug Evaluation and Research offered this explanation to the Associated Press: 'We've tried to weigh the risks of going forward with an uncertain message...with the level of uncertainty about the safety signal before us.'  

To read the rest of the article click here
 

Back to top

Click here to send to a friendShare thisPrinter friendly version



Post your comment

Name
 

Comment
(please add your comment
up to 1000 characters)
 

Email Address
(we will not publish this)
 




 Registered Office - Sea Containers House,
7th Floor, 20 Upper Ground, London SE1 9JD.

Agora Health Limited is registered in England and Wales
with company number 7141826 and VAT number GB 629 7287 94.

Copyright 2010  © Agora Health Ltd